- Author:
Sheng CHANG
1
;
Yana BAI
2
;
Hongquan PU
3
;
Ni LI
4
;
Ning CHENG
5
;
Haiyan LI
3
;
Zhidong XIE
2
;
Fuxin LI
3
;
Xiaobin HU
2
;
Jinbing ZHU
3
;
Jie HE
4
;
Min DAI
4
Author Information
- Publication Type:Journal Article
- MeSH: China; epidemiology; Colorectal Neoplasms; economics; mortality; Cost of Illness; Health Expenditures; statistics & numerical data; Humans; Retrospective Studies
- From: Chinese Journal of Epidemiology 2016;37(3):325-328
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the disease burden of colorectal cancer in Jinchang cohort, and provide evidence for preventing colorectal cancer and reducing the disease burden of colorectal cancer in the cohort.
METHODSThe colorectal cancer mortality data from 2001 to 2013 and the medical records of colorectal cancer patients from 2001 to 2010 were collected for this retrospective cohort study. The colorectal cancer disease burden was described by using mortality rate, standardized mortality rate, medical expenditure, potential years of life lost (PYLL), average potential years of life lost (APYLL), working potential years of life lost (WPYLL), and average working potential years of life lost (AWPYLL). The development trend in disease burden of colorectal cancer was analyzed by using Spearman correlation and the average growth rate.
RESULTSThe crude mortality rate of colorectal cancer from 2001 to 2013 was 9.53/100,000 with the average annual growth rate of 12.89%. The PYLL, APYLL, WPYLL and AWPYLL of colorectal cancer were 485.00 person-years, 9.15 years, 253.00 person-years, and 4.77 years, respectively. The direct medical expenditure due to colorectal cancer was 7064.38 Yuan per case and 408.43 Yuan per day. There was no increasing trend in the direct medical expenditure due to colorectal cancer.
CONCLUSIONColorectal cancer mortolity rate was on the rise and it caused heavy disease burden in Jinchang cohort.